Key result
Chronic chikungunya is linked to lower anti-CHIKV titers and reduced cytotoxicity versus self-resolving disease.
Why the study?
While the humoral immune response to CHIKV is well characterized, the contribution of Fc-mediated effector functions in disease pathogenesis remains poorly understood.
Are lower anti-CHIKV antibody titers and reduced Fc-mediated effector functions associated with chronic chikungunya disease?
Observational
Are lower anti-CHIKV antibody titers and reduced Fc-mediated effector functions associated with chronic chikungunya disease?
Lower anti-CHIKV antibody titers and reduced antibody-dependent cellular cytotoxicity at 6 months post-infection are associated with the development of chronic chikungunya.
Lower titers and ADCC at 6 months may flag chronic chikungunya risk; leaves open whether they drive persistence or mark failed clearance.
Infection due to the chikungunya virus (CHIKV) can cause chronic disease characterized by persistent arthralgia. While the humoral immune response to CHIKV is well characterized, the contribution of Fc-mediated effector functions in disease pathogenesis remains poorly understood. We assessed the quantitative and qualitative aspects of CHIKV-specific antibodies in patients with self-resolving or chronic chikungunya, including IgG/IgM titers and effector functions such as antibody-dependent cell phagocytosis (ADCP), complement deposition (ADCD), cell cytotoxicity (ADCC), and NK cell activation (ADNKA). Anti-CHIKV IgG and IgM titers declined between 3 and 6 months post-infection, and the lower titers at 6 months were associated with the chronic disease. The ADCP and ADCD capacities were similar between patients with self-resolving or chronic chikungunya. Patients with the chronic disease showed reduced ADCC but no reduced ADNKA. Females exhibited higher anti-CHIKV E2 antibody concentrations and ADCP. This study provides a comprehensive overview of Fc-mediated effector functions in chikungunya patients with differential disease outcomes.
No takes yet. Share an insight, caveat, or question.
Upasani et al. (2026) conducted an observational in Chikungunya. Chronic chikungunya vs. Self-resolving chikungunya was evaluated on Anti-CHIKV IgG/IgM titers and effector functions (ADCP, ADCD, ADCC, ADNKA). Chronic chikungunya was associated with lower anti-CHIKV IgG and IgM titers at 6 months post-infection and reduced antibody-dependent cell cytotoxicity compared to self-resolving disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: